These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 31826099)
1. Effects of childhood trauma on BDNF and TBARS during crack-cocaine withdrawal. Sordi AO; von Diemen L; Kessler FH; Schuch S; Ornell F; Kapczinski F; Pfaffenseller B; Gubert C; Wollenhaupt-Aguiar B; Salum GA; Pechansky F Braz J Psychiatry; 2020 Apr; 42(2):214-217. PubMed ID: 31826099 [TBL] [Abstract][Full Text] [Related]
2. Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal. Sordi AO; Pechansky F; Kessler FH; Kapczinski F; Pfaffenseller B; Gubert C; de Aguiar BW; de Magalhães Narvaez JC; Ornell F; von Diemen L Psychopharmacology (Berl); 2014 Oct; 231(20):4031-9. PubMed ID: 24676990 [TBL] [Abstract][Full Text] [Related]
3. High levels of brain-derived neurotrophic factor are associated with treatment adherence among crack-cocaine users. Scherer JN; Schuch S; Ornell F; Sordi AO; Bristot G; Pfaffenseller B; Kapczinski F; Kessler FHP; Fumagalli F; Pechansky F; von Diemen L Neurosci Lett; 2016 Sep; 630():169-175. PubMed ID: 27473943 [TBL] [Abstract][Full Text] [Related]
4. Differences in biomarkers of crack-cocaine adolescent users before/after abstinence. Pianca TG; Rosa RL; Ceresér KMM; de Aguiar BW; de Abrahão RC; Lazzari PM; Kapczinski F; Pechansky F; Rohde LA; Szobot CM Drug Alcohol Depend; 2017 Aug; 177():207-213. PubMed ID: 28618284 [TBL] [Abstract][Full Text] [Related]
5. Increase in brain-derived neurotrophic factor expression in early crack cocaine withdrawal. von Diemen L; Kapczinski F; Sordi AO; de Magalhães Narvaez JC; Guimarães LS; Kessler FH; Pfaffenseller B; de Aguiar BW; de Moura Gubert C; Pechansky F Int J Neuropsychopharmacol; 2014 Jan; 17(1):33-40. PubMed ID: 24067327 [TBL] [Abstract][Full Text] [Related]
6. TBARS and BDNF levels in newborns exposed to crack/cocaine during pregnancy: a comparative study. Mardini V; Rohde LA; Ceresér KM; Gubert CM; Silva EGD; Xavier F; Parcianello R; Röhsig LM; Pechansky F; Szobot CM Braz J Psychiatry; 2017; 39(3):263-266. PubMed ID: 28273279 [TBL] [Abstract][Full Text] [Related]
7. Serum BDNF levels increase during early drug withdrawal in alcohol and crack cocaine addiction. Ornell F; Scherer JN; Schuch JB; Sordi AO; Halpern SC; Rebelatto FP; Bristot G; Kapczinski F; Roglio VS; Pechansky F; Kessler FHP; von Diemen L Alcohol; 2023 Sep; 111():1-7. PubMed ID: 37037287 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of oxidative stress and brain-derived neurotrophic factor levels related to crack-use detoxification. Hirsch GE; Jaskulski M; Hamerski HM; Porto FG; da Silva B; Aita CAM; Kroker K; de Bem Silveira G; Silveira PCL; Santos GT; Klafke JZ; Viecili PRN Neurosci Lett; 2018 Mar; 670():62-68. PubMed ID: 29374540 [TBL] [Abstract][Full Text] [Related]
9. Changes in brain-derived neurotrophic factor (BDNF) during abstinence could be associated with relapse in cocaine-dependent patients. Corominas-Roso M; Roncero C; Daigre C; Grau-Lopez L; Ros-Cucurull E; Rodríguez-Cintas L; Sanchez-Mora C; Lopez MV; Ribases M; Casas M Psychiatry Res; 2015 Feb; 225(3):309-14. PubMed ID: 25592977 [TBL] [Abstract][Full Text] [Related]
10. Distinct behavioral and immunoendocrine parameters during crack cocaine abstinence in women reporting childhood abuse and neglect. Levandowski ML; Viola TW; Prado CH; Wieck A; Bauer ME; Brietzke E; Grassi-Oliveira R Drug Alcohol Depend; 2016 Oct; 167():140-8. PubMed ID: 27530287 [TBL] [Abstract][Full Text] [Related]
11. Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress. Viola TW; Tractenberg SG; Levandowski ML; Pezzi JC; Bauer ME; Teixeira AL; Grassi-Oliveira R J Psychiatry Neurosci; 2014 May; 39(3):206-14. PubMed ID: 24331739 [TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence. Corominas-Roso M; Roncero C; Eiroa-Orosa FJ; Gonzalvo B; Grau-Lopez L; Ribases M; Rodriguez-Cintas L; Sánchez-Mora C; Ramos-Quiroga JA; Casas M Eur Neuropsychopharmacol; 2013 Sep; 23(9):1078-84. PubMed ID: 23021567 [TBL] [Abstract][Full Text] [Related]